---
layout: single
title: "Publication"
permalink: /publication/
author_profile: true
---


üîó [View full list on Google Scholar]   https://scholar.google.com/citations?user=EtUtLTkAAAAJ&hl=en

# üìù Publications

## Manuscripts In Submission (# co-first author)

- Huang, L.#, Liu P.P.#, Du, Y.#, Pan, D.N., Chen, Q.B., Wang, Y.X.  
  *A novel adipokine suppresses leptin signaling and food intake.*  
  _Nature Metabolism_, In revision. (UMass Medical School)

---

## Publications in Microbiology and Immunology

- Du Y#, Faz-Lopez B#, Ah Kioon MD, Cenac C, Pierides M, Lakin K, Spiera RF, Chaumeil J, Truchetet ME, Gordon JK, Gu√©ry JC*, Barrat FJ* (2025).  
  *Altered X-chromosome inactivation of the TLR7/8 locus and heterogeneity of plasmacytoid DCs in systemic sclerosis.*  
  _The Journal of Experimental Medicine_, **222**(3): e20231809.

- Du Y, Ah Kioon MD, Laurent P, Chaudhary V, Pierides M, Yang C, Oliver D, Ivashkiv LB, Barrat FJ (2022).  
  *Chemokines form nanoparticles with DNA and can superinduce TLR-driven immune inflammation.*  
  _The Journal of Experimental Medicine_, **219**(7): e20212142.

- Xiao X#, Du Y#, Sun S, Su X, Xing J, Wang G, Elzein SM, Zou D, Minze LJ, Mao Z, Ghobrial RM, Conner AA, Chen W, Zhang Z, Li XC (2024).  
  *Apex1 safeguards genomic stability to ensure a cytopathic T cell fate in autoimmune disease models.*  
  _J Clin Invest_, **135**. 10.1172/JCI183671
        
        
        
        
        
        
        
        
        
        
        
        
        
        .

- Wang JY#, Lu WT#, Zhang J#, Du Y#, Fang ML, Xing JJ (2024).  
  *Loss of TRIM29 mitigates viral myocarditis by attenuating PERK-driven ER stress and ROS responses in male mice.*  
  _Nature Communications_, **15**: 3481.

- Ah Kioon MD#, Laurent P#, Chaudhary V#, Du Y#, Crow MK, Barrat FJ (2024).  
  *Modulation of plasmacytoid dendritic cells response in inflammation and autoimmunity.*  
  _Immunological Reviews._

- Xiong D#, Du Y#, Wang HB#, Zhao B#, Zhang H, Li Y, Hu LJ, Cao JY, Zhong Q, Liu WL, et al. (2015).  
  *Nonmuscle myosin heavy chain IIA mediates Epstein-Barr virus infection of nasopharyngeal epithelial cells.*  
  _PNAS_, **112**: 11036‚Äì11041. _(Part of my Ph.D. thesis)_

- Chaudhary V, Mishra B, Ah Kioon MD, Du Y, Barrat F.  
  *Regulation of NRF2 in plasmacytoid DCs determines resolution versus fibrosis in the skin.*  
  _The Journal of Experimental Medicine_, Accepted.

- Cakan E, Ah Kioon MD, Garcia-Carmona Y, Glauzy S, Oliver D, Yamakawa N, Vega Loza A, Du Y, Schickel JN, Boeckers JM, et al. (2023).  
  *TLR9 ligand sequestration by chemokine CXCL4 negatively affects central B cell tolerance.*  
  _The Journal of Experimental Medicine_, **220**.

- Yang C, Bachu M, Du Y, Brauner C, Yuan R, Ah Kioon MD, Chesi G, Barrat FJ, Ivashkiv LB (2022).  
  *CXCL4 synergizes with TLR8 for TBK1-IRF5 activation, epigenomic remodeling and inflammatory response in human monocytes.*  
  _Nature Communications_, **13**: 3426.

- Xia Y, Inoue K, Du Y, Baker SJ, Reddy EP, Greenblatt MB, Zhao B (2022).  
  *TGFŒ≤ reprograms TNF stimulation of macrophages towards a non-canonical pathway driving inflammatory osteoclastogenesis.*  
  _Nature Communications_, **13**: 3920.

- Xing J, Zhang A, Du Y, Fang M, Minze LJ, Liu YJ, Li XC, Zhang Z (2021).  
  *PARP9 is a noncanonical sensor for RNA virus in dendritic cells.*  
  _Nature Communications_, **12**: 2681.

- Zhang A, Xing J, Xia T, Zhang H, Fang M, Li S, Du Y, Li XC, Zhang Z, Zeng MS (2020).  
  *EphA2 phosphorylates NLRP3 and inhibits inflammasomes in airway epithelial cells.*  
  _EMBO Reports_, **21**: e49666.

- Zhang H, Li Y, Wang HB, Zhang A, Chen ML, Fang ZX, Dong XD, Li SB, Du Y, Xiong D, et al. (2018).  
  *Ephrin receptor A2 is an epithelial cell receptor for Epstein-Barr virus entry.*  
  _Nature Microbiology_, **3**: 1‚Äì8.

- Ni C, Chen Y, Zeng M, Pei R, Du Y, Tang L, Wang M, Hu Y, Zhu H, He M, et al. (2015).  
  *In-cell infection: a novel pathway for Epstein-Barr virus infection mediated by cell-in-cell structures.*  
  _Cell Research_, **25**: 785‚Äì800.

- Wang HB, Zhang H, Zhang JP, Li Y, Zhao B, Feng GK, Du Y, Xiong D, Zhong Q, Liu WL, et al. (2015).  
  *Neuropilin 1 is an entry factor that promotes EBV infection of nasopharyngeal epithelial cells.*  
  _Nature Communications_, **6**: 6240.

---

## Publications in Cancer Biology

- Du Y#, Liu L#, Wang C#, Kuang B, Yan S, Zhou A, Wen C, Chen J, Wu Y, Yang X, et al. (2016).  
  *TACC3 promotes colorectal cancer tumourigenesis and correlates with poor prognosis.*  
  _Oncotarget_, **7**: 41885‚Äì41897.

- Du Y#, Yan SM#, Gu WY, He F, Huang LY, Li M, Yuan Y, Chen RH, Zhong Q, Li MZ, et al. (2015).  
  *Decreased Expression of FADS1 Predicts Poor Prognosis in Esophageal Squamous Cell Carcinoma.*  
  _Asian Pacific Journal of Cancer Prevention_, **16**: 5089‚Äì5094.

- Dai DN#, Li Y#, Chen B#, Du Y#, Li SB, Lu SX, Zhao ZP, Zhou AJ, Xue N, Xia TL, et al. (2017).  
  *Elevated expression of CST1 promotes breast cancer progression and predicts poor prognosis.*  
  _Journal of Molecular Medicine_, **95**: 873‚Äì886.

- Yuan Y#, Du Y#, Hu XY, Liu MY, Du JK, Liu XM, Yu HE, Wang TZ, Pu JX, Zhong Q, et al. (2017).  
  *Longikaurin A suppresses stemness in nasopharyngeal carcinoma cells.*  
  _Oncology Letters_, **13**: 1672‚Äì1680.

- Chen RH#, Du Y#, Han P, Wang HB, Liang FY, Feng GK, Zhou AJ, Cai MY, Zhong Q, Zeng MS, et al. (2016).  
  *ISG15 predicts poor prognosis and promotes cancer stem cell phenotype in nasopharyngeal carcinoma.*  
  _Oncotarget_, **7**: 16910‚Äì16922.

- Li RC#, Du Y#, Zeng QY#, Tang LQ, Zhang H, Li Y, Liu WL, Zhong Q, Zeng MS, Huang XM (2016).  
  *Antibodies Against EBV gp42 for Diagnosis of Nasopharyngeal Carcinoma.*  
  _Clinical Laboratory_, **62**: 553‚Äì561.

- Li RC#, Du Y#, Zeng QY#, Tang LQ, Zhang H, Li Y, Liu WL, Zhong Q, Zeng MS, Huang XM (2016).  
  *EBV gH/gL antibodies complement IgA-VCA for NPC diagnosis.*  
  _Oncotarget_, **7**: 16372‚Äì16383.

---

## üìú Patent

- Wang Y.X., Huang L., Du Y. (2019).  
  *Methods for improving leptin sensitivity for the treatment of obesity and diabetes.*  
  WO/2019/21770.
